The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, pose a risk to public health.
The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. Article HereZantac or Ranitidine first came out in 1981 and by 1987 it was the most prescribed drug in the world for decreasing stomach acid production. Fast forward almost 40 years later and we find out that Zantac should really not be exposed to heat. When exposed to heat in the body, the chemical called N-nitrosodimethylamine, or NDMA, a probable human carcinogen is created.
In the almost 40 years on the market, no warning was ever given on this and we could be talking about a whole lot of people exposed and at risk. In 2016 there where more than 15 million Americans with a prescription to Zantac (not counting the people that got it over the counter.)
The cancers that could be tied to Zantac are: Bladder Cancer, Stomach Cancer, Small Intestine Cancer, Colorectal Cancer, Esophageal Cancer, Liver Cancer, Pancreatic Cancer, Testicular Cancer, Uterine Cancer, Kidney Cancer
We have been finding clients for this tort for the last few months and we have setup attorneys if you are interested in ref. the cases out. We are seeing case costs currently running backing into $1000-1200 per cancer case. You can see our statistics on this tort here |
The link below is to the online automated application for SBA’s Paycheck Protection Program (PPP).
